文献速递MDS 与骨髓增殖性肿瘤血栓与止血

骨髓纤维化中的血小板减少以炎症性巨核细胞及G6B表达降低为特征

Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression.
PubMed 文献 · Blood · 2025-01-01

研究探讨G6b-B在骨髓增殖性肿瘤相关骨髓纤维化伴血小板减少(MPN-MF-T)中的作用,发现患者来源巨核细胞不表达GATA1和G6B,呈炎症预激活表型,且TGFβ1与YKL-40形成正反馈环路,共同阻碍巨核细胞成熟。

要点

  • MPN-MF-T患者巨核细胞不表达GATA1和G6B,呈炎症性而非产血小板表型。
  • MPN-MF-T较MPN-MF-NT生成更少巨核偏向造血干细胞和更多CD41+CD42-G6B-未成熟巨核细胞。
  • MPN-MF-T患者TNFα和YKL-40水平较MPN-MF-NT上调更显著,TGFβ1两者相似升高。

核心结论

  • 巨核细胞成熟受损及G6B表达降低导致促炎性巨核细胞占优势,其产生的因子进一步阻碍MF-MPIG6B和MPN-MF-T患者的巨核细胞发育。

研究设计与样本

  • 研究比较了MPN-MF-T、非血小板减少性MPN-MF(MPN-MF-NT)及MF-MPIG6B患者来源单核细胞生成的巨核细胞。
  • 试验注册号为NCT03895112。

主要发现

  • MF-MPIG6B及MPN-MF-T患者来源巨核细胞不表达GATA结合蛋白1和G6B,呈炎症预激活蛋白表达模式。
  • MPN-MF-T较MPN-MF-NT生成更少巨核偏向造血干细胞和更多小胞质未成熟巨核细胞(CD41+CD42-G6B-)。
  • MF-MPIG6B患者血浆TGFβ1和YKL-40(CHI3L1)水平升高。
  • MPN-MF-T与MPN-MF-NT患者血浆TGFβ1水平相似升高,但MPN-MF-T患者TNFα和YKL-40水平较MPN-MF-NT上调更显著。
  • 在MF巨核细胞中鉴定出TGFβ1与YKL-40之间的相互正反馈调节环路。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The megakaryocytic (MK)-specific immunoreceptor G6b-B plays an essential role in MK development. Because germ line loss-of-function mutations of G6b-B in humans and its deletion in mouse models lead to thrombocytopenia and a myelofibrosis-like clinical phenotype (MF-MPIG6B), we explored the role of G6b-B in patients with myelofibrosis (MF) due to a myeloproliferative neoplasm (MPN) with thrombocytopenia (MPN-MF-T). We demonstrated that MKs generated from mononuclear cells (MNCs) from a patient with MF-MPIG6B as well as patients with MPN-MF-T failed to express GATA binding protein 1 and G6B and possessed a protein pattern expression characteristic of MKs primed for inflammation rather than platelet production. MNCs from patients with MPN-MF-T also generated fewer MK-biased hematopoietic stem cells and greater numbers of small cytoplasmic immature MKs (CD41+CD42-G6B-) as compared with MNCs from patients with nonthrombocytopenic MPN-MF (MPN-MF-NT). Plasma levels of transforming growth factor β1 (TGFβ1) and chitinase-3-like protein (CHI3L1) also known as YKL-40, which were shown to arrest normal MK maturation, were elevated in the patients with MF-MPIG6B. Although TGFβ1 plasma levels were similarly elevated in patients with MPN-MF-T and MPN-MF-NT, tumor necrosis factor α (TNFα) and YKL-40 levels were upregulated to a greater extent in patients with MPN-MF-T than those with MPN-MF-NT. Moreover, we identified a reciprocal positive regulatory loop involving TGFβ1 and YKL-40 in MF MKs. These findings indicate that impaired MK maturation, and reduced G6B expression lead to the predominance of proinflammatory MKs, which produce factors that further arrest MK development in patients with MF-MPIG6B and MPN-MF-T patients. This trial was registered at www.clinicaltrials.gov as #NCT03895112.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Varricchio L, Mosoyan G, Elghaity-Beckley S, et al. Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression. Blood. 2025. PMID: 40643151. doi:10.1182/blood.2024027363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。